Arkolith/Insider Trading/MLYS/Form 4

Rodman David Malcom

Chief Medical OfficerMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed May 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$653K
Net Open-Market Flow
-$653K
Transactions
11
7 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2026Option exercise(M)4K$14.25$59K77K
May 13, 2026Sell(S)14K$28.58$402K63K
May 13, 2026Option exercise(M)4K$10.20$36K73K
May 12, 2026Option exercise(M)6K$1.08$7K76K
May 12, 2026Sell(S)6K$29.36$186K70K
May 11, 2026Option exercise(M)2K$16.00$35K72K
May 11, 2026Sell(S)2K$29.71$65K70K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 13, 2026Option exercise(M)4K—$0117K
May 13, 2026Option exercise(M)4K—$088K
May 12, 2026Option exercise(M)6K—$013K
May 11, 2026Option exercise(M)2K—$020K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001672659-26-000027) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML